Board of Pharmacy Update Allison Vordenbaumen Benz, R.Ph., M.S. - - PowerPoint PPT Presentation

Board of Pharmacy Update

Allison Vordenbaumen Benz, R.Ph., M.S. Executive Director Texas Federation of Drug Stores Meeting October 16, 2019

Goals

• H.B. 3284 – PMP Advisory Committee
• H.B. 2174 – E-prescribing
• H.B. 2088 – Drug Take Back
• Integration & NarxCare
• Board Updates

Board of Pharmacy Members

Julie Spier, R.Ph. President – Katy Bradley A. Miller, Ph.T.R. Vice-President – Austin Donnie Lewis, R.Ph. Treasurer – Athens Jenny Downing Yoakum, R.Ph. Kilgore Rick Fernandez, R.Ph. North Lake Daniel Guerrero San Marcos Lori Henke, Pharm.D. Amarillo Donna Monternayor, R.Ph. San Antonio Chip Thornsburg San Antonio Suzette Tijerina, R.Ph. Castle Hills Rick Tisch Spring

H.B. 3284 Prescription Monitoring Program Advisory Committee

Purpose

• to make recommendations regarding

information submitted to the board and access to that information, including recommendations for:

– operational improvements to the electronic system

that stores the information, including implementing best practices and improvements that address system weaknesses and workflow challenges;

Purpose (cont.)

– resolutions to identified data concerns; – methods to improve data accuracy, integrity,

and security and to reduce technical difficulties; and

– the addition of any new data set or service to

the information submitted to the board or the access to that information.

Members

• physician licensed in this state who practices

in pain management;

• physician licensed in this state who practices

in family medicine;

• physician licensed in this state who performs

surgery;

• physician licensed in this state who practices

in emergency medicine at a hospital;

Members (cont.)

• physician licensed in this state who practices

in psychiatry;

• oral and maxillofacial surgeon;
• physician assistant or advanced practice

registered nurse to whom a physician has delegated the authority to prescribe or order a drug;

• pharmacist working at a chain pharmacy;

Members (cont.)

• pharmacist working at an independent

pharmacy;

• academic pharmacist; and
• two representatives of the health

information technology industry, at least

• ne of whom is a representative of a

company whose primary line of business is electronic medical records.

Members (cont.)

• Members of the advisory committee:

– serve three-year terms. – serve until the member’s replacement has

been appointed.

• The advisory committee shall:

– annually elect a presiding officer from its

members.

– meet at least two times a year and at the call

• f the presiding officer or the board.

H.B. 2174 Electronic Prescribing

E-Prescribing

• Effective January 1, 2021
• All controlled substances
• Waivers
• Interagency Workgroup

H.B. 2174

• Limits prescriptions for opioids for the

initial treatment of acute pain to a 10-day supply (no refills).

• Requires two hours of continuing

education regarding approved monitoring controlled substances.

H.B. 2088 Drug Take Back

Drug Take Back

• A person dispensing a Schedule II

controlled substance under a prescription shall provide written notice on the safe disposal of controlled substance prescription drugs, unless:

Drug Take Back (cont.)

• the schedule II controlled substance

prescription drug is dispensed at a pharmacy

• r other location that:

– is authorized to take back those drugs for safe

disposal; and

– regularly accepts those drugs for safe disposal; or

Drug Take Back (cont.)

– the dispenser provides to the person to whom

the schedule II controlled substance prescription drug is dispensed, at the time of dispensation and at no cost to the person:

• a mail-in pouch for surrendering unused controlled

substance prescription drugs; or

• chemicals to render any unused drugs unusable or

non-retrievable.

Board Rule 315.3

• §315.3 Prescriptions

– A person dispensing a Schedule II controlled

substance prescription shall provide written notice on the safe disposal of controlled substance prescription drugs that includes information on locations at which Schedule II controlled substance prescription drugs are accepted for safe disposal.

Board Rule 315.3 (cont.)

– In lieu of listing those locations, the notice

may alternatively provide the address of an Internet website specified by the board that provides a searchable database of locations at which Schedule II controlled substance prescription drugs are accepted for safe

• disposal. Such written notice is not required

if:

Board Rule 315.3 (cont.)

• the Schedule II controlled substance prescription

drug is dispensed at a pharmacy or other location that:

– is authorized to take back those drugs for safe disposal;

and

– regularly accepts those drugs for safe disposal; or

• the dispenser provides to the person to whom the

Schedule II controlled substance prescription drug is dispensed, at the time of dispensation and at no cost to the person:

Board Rule 315.3 (cont.)

• a mail-in pouch for surrendering unused controlled

substance prescription drugs; or

• chemicals to render any unused drugs unusable or

non-retrievable.

Integration & NarxCare

Integration

• S.B. 500 - $6 million+ for integration and
• ther enhancements
• No charge to entity from Appriss

NarxCare

• Overdose risk score

NarxCare Scores

In a typical population:

• 75% will have a score less than 200
• 5% will have a score above 500
• 1% will have a score above 650

Board Updates

New Staff

• LEAP – 1 attorney, 1 analyst
• Patient Access – 2 analysts
• Epidemilogist
• 2 compliance officers
• 1 investigator
• 1 legal assistant
• 1 administrative assistant – open records

Strategic Plan - Issues

• Combat Nontherapeutic Dispensing of

Controlled Substances Contributing to the Opioid Epidemic

– e-prescribing; – Prescription Monitoring Program integration; – NarxCare.

Strategic Plan – Issues (cont.)

• Monitor Increased Use of Technology in the

Practice of Pharmacy to Integrate Technological Advances into Texas Pharmacy Regulations

– receipt and data entry of prescriptions and

patient information;

– storage of prescription information; – delivery of pharmacy services; – accountability for pharmacy services; – use of the Internet.

Strategic Plan – Issues (cont.)

• Address Appropriate Level of Training and

Supervision for Pharmacy Technicians in Order to Increase Pharmacists’ Ability to Provide Clinical Services

Strategic Plan – Issues (cont.)

• Increase Licensee Compliance with Laws

and Rules Relating to the Practice of Pharmacy through Education of Licensees

– opioid dispensing; – implementation of mobile inspections.

Board Meetings

• November Board meeting - begin

streaming to public

• Comments on Rules

– Proposed rules must be posted in the Texas

Register for 30 days

Questions?

Thank you!